The Challenge: Inadequate Patient Engagement in Oncology
Oncologists are facing a critical challenge of inadequate patient engagement. Current methods often fail to effectively educate patients on cancer treatment options, side effects management, and supportive care, leading to suboptimal treatment adherence and health outcomes.
Research shows that 80% of cancer patients feel overwhelmed by treatment decisions and lack sufficient information to make informed choices, resulting in anxiety and uncertainty.
The Impact of Ineffective Engagement
For pharmaceutical product managers and marketers, the consequences are profound. Without robust patient engagement:
- Pharmaceutical companies miss opportunities to tailor therapies and supportive care products to meet patient needs, impacting market penetration and patient satisfaction.
- There’s a noticeable decline in patient trust and satisfaction due to ineffective educational resources and lack of personalized treatment plans.
- Digital engagement tools remain underutilized, limiting the reach and impact of educational initiatives on cancer care.
This disconnect not only affects patient quality of life but also leads to increased healthcare costs as complications from untreated or poorly managed side effects arise.
Our Solution: Transforming Oncologist Engagement
At Pixika AI, we specialize in transforming oncologist engagement through advanced digital solutions. Our approach integrates best practices in patient education, personalized product strategies, and seamless web-to-web interactions.
Why Choose Pixika AI?
With over 70 top global healthcare companies trusting our expertise, Pixika AI has empowered 500,000 doctors annually with effective digital and print initiatives. We’ve facilitated over 1 million personalized inputs, contributing to a cumulative revenue of 9700 crores for our clients.
Partnering with 650+ healthcare brands across 8 countries, we maintain a stellar 75% repeat customer rate and an average rating of 4.1 stars.